Gavin M. Marx

机构：Australian National University, Sydney Adventist Hospital · ORCID：0000-0002-1016-6544

发表论文 200 篇 · 总被引 6051 次 · h-index 34

代表论文

• Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study (2025 · Journal of Clinical Oncology · 被引 47)
• Oral Cannabis Extract for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting: Final Results of a Randomized, Placebo-Controlled, Phase II/III Trial (2024 · Journal of Clinical Oncology · 被引 32)
• Validity of Patient-Reported Outcome Measures in Evaluating Nerve Damage Following Chemotherapy (2024 · JAMA Network Open · 被引 27)
• Prognostic implications of PSA levels at 7 months in metastatic hormone-sensitive prostate cancer treated with enzalutamide: Landmark analysis of ENZAMET (ANZUP 1304). (2024 · Journal of Clinical Oncology · 被引 12)
• Impact of Pain on Symptom Burden in Chemotherapy-Induced Peripheral Neurotoxicity (2024 · Journal of the National Comprehensive Cancer Network · 被引 11)
• Clinical validation of circulating GDF15/MIC‐1 as a marker of response to docetaxel and survival in men with metastatic castration‐resistant prostate cancer (2024 · The Prostate · 被引 10)